Abeona Share Price

Abeona Share Price

NASDAQ: ABEO | Micro Cap | Healthcare
$2.73
+$0.13 (5.00%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Abeona Stock Performance

Open
$2.59
Prev. Close
$2.60
Circuit Range
N/A
Day Range
$2.58 - $2.78
Year Range
$2.09 - $7.62
Volume
87,474
Average Traded
$2.73

Abeona Share Price Today

As of 19 November 2026, Abeona Therapeutics Inc.'s share price is $2.73. The stock opened at $2.59, compared to its previous close of $2.60. During today's trading session, Abeona Therapeutics Inc.'s share price traded between $2.58 and $2.78, with an average price of $2.68. Over the past 52 weeks, the stock has recorded a high of $7.62 and a low of $2.09. In terms of performance, Abeona Therapeutics Inc.'s share price has declined by 52.93% over the last six months and is down 46.05% on a year-on-year basis.

Abeona Share Price Chart

Line chart of the Abeona price trend over the selected period. The price rose overall, ranging from 2.58 to 2.78, ending at 2.73.
$2.58$2.78
L
Show Current Price
H

Abeona Stock Fundamentals & Key Indicators

Market Cap
$144.56M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.01
Revenue (TTM)
$5.82B
Return On Equity (TTM)
-49.68%
Profit Margin
1223.02%
Debt to Equity
0.09
Quarterly Earnings Growth YoY
76.49%

Abeona Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$5.42$8.72$11.38$13.49
Net Profit-$20.46-$17.08-$20.19-$4.81
Net Profit Margin-377.49%-195.87%-177.42%-35.66%
Income ChangeN/A16.52%-18.21%76.18%

Abeona Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1.41$3.50$0.00$5.82
Net Profit-$43.48-$54.19-$63.73$71.18
Net Profit Margin-3083.69%-1548.29%N/A1223.02%
Income ChangeN/A-24.63%-17.60%211.69%

Abeona Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets14.668.088.2711.12
Current Assets204.91100.8555.7453.1
Total Assets219.57108.9364.064.21
Non Current Liabilities30.7848.3135.7529.67
Current Liabilities29.5716.5913.427.78
Total Liabilities60.3564.949.1837.45
Shareholders' Equity159.2244.0314.8326.76

Abeona Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-76.33-56.02-37.01-43.48
Investing105.03-39.240.21-23.96
Financing26.04104.1437.0643.17

Corporate Actions

Split
Ex-date: 05 Jul 2022

About Abeona

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

Abeona Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$4.38
$2.73
-37.21%
Oct 2026
$5.21
$4.34
-17.65%
Sep 2026
$5.85
$5.27
-12.89%
Aug 2026
$6.34
$6.05
-5.91%
Jul 2026
$6.29
$6.43
+4.47%
Jun 2026
$5.64
$6.16
+6.12%
May 2026
$5.46
$5.80
+6.52%
Apr 2026
$4.51
$5.45
+21.27%
Mar 2026
$5.09
$4.49
-12.48%
Feb 2026
$5.05
$5.13
+0.79%
Jan 2026
$5.22
$5.09
-3.51%
Dec 2025
$4.98
$5.28
+4.25%

Abeona Share Price FAQs